Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(1507)
•••
Comment by wildbird1on Aug 07, 2019 10:05am
146 Views
Post# 30001489

RE:No cheap warrants unloaded...

RE:No cheap warrants unloaded...
Members on this board that read my posts know that I try as much as possible to provide truthful informations.

This morning the new shares out numbers on TSX just came out. The new share out number is 227,232,793... so that make my post below invalid.

Sorry...

wildbird1 wrote: We keep asking why the Bot is constantly trying to get the SP lower.

On June 5, 2019 the number of shares out from SZLS was 194,985,251 (total shares 202,210,715).
Today the number of shares out is still 194,985,251 ( meaning no warrants were unloaded during that period)

Why the bot???
We can rule out the unloading of cheap warrants from Lind( or anybody else).
It has nothing to do with refinancing at a lower price, SZLS has $3.7 million in the Bank.

2 Questions???? 
-Why is the bot trying to get the SP down?...(My guess is somebody accumulating).
-What is the reason nobody is trying to unload cheap warrants (since 5 June, 2019)?...






Bullboard Posts
Dealroom for high-potential pre-IPO opportunities